PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CAH vs. BIIB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CAH and BIIB is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

CAH vs. BIIB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cardinal Health, Inc. (CAH) and Biogen Inc. (BIIB). The values are adjusted to include any dividend payments, if applicable.

4,000.00%5,000.00%6,000.00%7,000.00%8,000.00%JulyAugustSeptemberOctoberNovemberDecember
5,269.84%
5,381.52%
CAH
BIIB

Key characteristics

Sharpe Ratio

CAH:

0.82

BIIB:

-1.26

Sortino Ratio

CAH:

1.23

BIIB:

-1.78

Omega Ratio

CAH:

1.16

BIIB:

0.79

Calmar Ratio

CAH:

1.00

BIIB:

-0.50

Martin Ratio

CAH:

2.16

BIIB:

-1.45

Ulcer Index

CAH:

8.43%

BIIB:

22.40%

Daily Std Dev

CAH:

22.27%

BIIB:

25.75%

Max Drawdown

CAH:

-61.68%

BIIB:

-90.24%

Current Drawdown

CAH:

-2.05%

BIIB:

-64.01%

Fundamentals

Market Cap

CAH:

$30.31B

BIIB:

$23.45B

EPS

CAH:

$5.10

BIIB:

$10.94

PE Ratio

CAH:

24.09

BIIB:

14.56

PEG Ratio

CAH:

1.04

BIIB:

6.24

Total Revenue (TTM)

CAH:

$224.50B

BIIB:

$9.41B

Gross Profit (TTM)

CAH:

$7.44B

BIIB:

$6.75B

EBITDA (TTM)

CAH:

$2.57B

BIIB:

$2.90B

Returns By Period

In the year-to-date period, CAH achieves a 23.53% return, which is significantly higher than BIIB's -39.03% return. Over the past 10 years, CAH has outperformed BIIB with an annualized return of 7.29%, while BIIB has yielded a comparatively lower -6.85% annualized return.


CAH

YTD

23.53%

1M

6.21%

6M

25.84%

1Y

17.64%

5Y (annualized)

21.15%

10Y (annualized)

7.29%

BIIB

YTD

-39.03%

1M

-9.53%

6M

-30.01%

1Y

-34.02%

5Y (annualized)

-12.09%

10Y (annualized)

-6.85%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CAH vs. BIIB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cardinal Health, Inc. (CAH) and Biogen Inc. (BIIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CAH, currently valued at 0.82, compared to the broader market-4.00-2.000.002.004.000.82-1.26
The chart of Sortino ratio for CAH, currently valued at 1.23, compared to the broader market-4.00-2.000.002.004.001.23-1.78
The chart of Omega ratio for CAH, currently valued at 1.16, compared to the broader market0.501.001.502.001.160.79
The chart of Calmar ratio for CAH, currently valued at 1.00, compared to the broader market0.002.004.006.001.00-0.50
The chart of Martin ratio for CAH, currently valued at 2.16, compared to the broader market0.0010.0020.0030.002.16-1.45
CAH
BIIB

The current CAH Sharpe Ratio is 0.82, which is higher than the BIIB Sharpe Ratio of -1.26. The chart below compares the historical Sharpe Ratios of CAH and BIIB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.82
-1.26
CAH
BIIB

Dividends

CAH vs. BIIB - Dividend Comparison

CAH's dividend yield for the trailing twelve months is around 1.64%, while BIIB has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
CAH
Cardinal Health, Inc.
1.64%1.98%2.57%3.80%3.62%3.79%4.24%2.99%2.41%1.68%1.65%1.77%
BIIB
Biogen Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%6.98%0.00%0.00%0.00%0.00%

Drawdowns

CAH vs. BIIB - Drawdown Comparison

The maximum CAH drawdown since its inception was -61.68%, smaller than the maximum BIIB drawdown of -90.24%. Use the drawdown chart below to compare losses from any high point for CAH and BIIB. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-2.05%
-64.01%
CAH
BIIB

Volatility

CAH vs. BIIB - Volatility Comparison

Cardinal Health, Inc. (CAH) has a higher volatility of 7.15% compared to Biogen Inc. (BIIB) at 5.82%. This indicates that CAH's price experiences larger fluctuations and is considered to be riskier than BIIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
7.15%
5.82%
CAH
BIIB

Financials

CAH vs. BIIB - Financials Comparison

This section allows you to compare key financial metrics between Cardinal Health, Inc. and Biogen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab